Skip to main content

and
  1. Article

    Open Access

    Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

    Lauren K. Shea, Kazuhito Honjo, David T. Redden, Edlue Tabengwa in Blood Cancer Journal (2019)

  2. No Access

    Article

    Growth mechanism of human myeloma cells by interleukin-6

    Human myeloma cells are heterogenous morphologically and phenotypically. Myeloma cells can be classified into at least 5 subpopulations; MPC-1-CD45+CD49e-, MPC-1-CD45-CD49e- immature myeloma cells, MPC-1+CD45-...

    Michio M. Kawano, Hideaki Ishikawa, Naohiro Tsuyama in International Journal of Hematology (2002)